# Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)

> **NCT00959400** · PHASE3 · WITHDRAWN · sponsor: **Cristália Produtos Químicos Farmacêuticos Ltda.**

## Conditions studied

- Pain
- Palliative Care

## Interventions

- **DRUG:** Fentanyl Transdermal

## Key facts

- **NCT ID:** NCT00959400
- **Lead sponsor:** Cristália Produtos Químicos Farmacêuticos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** 2011-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959400, "Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00959400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*